Clinical-epidemiological profile of patients with liver cancer treated at a tertiary center: A cross-sectional study
DOI:
https://doi.org/10.33448/rsd-v14i2.48318Keywords:
Liver neoplasms; Liver; Hepatocellular carcinoma; Epidemiology.Abstract
Objective: To outline the clinical and epidemiological profile of patients diagnosed with liver cancer treated at a tertiary health center. Methods: This is a cross-sectional study, which collected, in a non-probabilistic way, data from the medical records of patients treated at the Hospital de Clínicas, Passo Fundo - RS, between January 2011 and December 2020. The findings were categorized into data from identification and sociodemographic data, health characteristics, hospital case outcome and liver cancer outcome. Results: Of the 117 patients, 65% were men. A total of 91% were white, aged 68 ± 14 years. Of the liver tumors, 40% corresponded to liver metastases, while among the primary neoplasms, hepatocellular carcinoma was responsible for 86% of the diagnoses. Of the diagnoses of hepatocellular carcinoma, there was a predominance of males, with 80% of cases aged 71 ± 9.5 years. Of the risk factors associated with neoplasia, alcoholic cirrhosis was the most prevalent (52%), being mainly related to males. Conclusion: Liver cancer is more prevalent in men with a mean age of 68 years. Of the liver cancers, hepatocellular carcinoma has the highest prevalence, with a clinical profile well outlined in the literature, affecting mainly men over 70 years of age with liver cirrhosis associated with excessive alcohol intake and infection with hepatitis C and B viruses. Part of the etiological components and risk factors for hepatocellular carcinoma are preventable and avoidable.
References
Alfonso, L., Armas, S., María, D., Andara Ramírez, T., & Pedroso, G. N. (2015). Metástasis hepática como forma de presentación de cáncer. Revista Cubana de Oncología, 54(1), 23-30.
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of internal medicine, 144(10), 705-714. https://doi.org/10.7326/0003-4819-144-10-200605160-00004
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004). Primary liver cancer: Worldwide incidence and trends. Gastroenterology, 127(5), S5-S16. https://doi.org/10.1053/j.gastro.2004.09.011
Cabarcas, R. G., Olarte, H., & de Pabón, E. C. (1996). Tumores Primarios Malignos del Hígado. Estudio de 18 Casos y Revisión de la Bibliografía. Revista Colombiana de Cirugía, 11(4), 355-365.
Carrilho, F. J., Kikuchi, L., Branco, F., Gonçalves, C. S., de Mattos, A. A., & Brazilian HCC Study Group. (2010). Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Clinics, 65(12), 1285-1290. https://doi.org/10.1590/S1807-59322010001200010
Carrilho, F. J., Paranaguá-Vezozzo, D. C., Chagas, A. L., Alencar, R. S. de S. M., & Da Fonseca, L. G. (2020). Epidemiology of liver cancer in Latin America: Current and future trends. Seminars in Liver Disease, 40(2), 101-110. https://doi.org/10.1055/s-0039-3399561
Chedid, MF, Kruel, CR, Pinto, MA, Grezzana-Filho, TJ, Leipnitz, I., Kruel, CD, ... & Chedid, AD. (2017). Hepatocellular carcinoma: Diagnosis and operative management. ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 30(4), 272-278. https://doi.org/10.1590/0102-6720201700040011
Cisneros Garza, L. E., & Aiza Haddad, I. (2022). Hepatocellular carcinoma in Mexico. Clinical Liver Disease (Hoboken), 19(2), 73-77. https://doi.org/10.1002/cld.119
Cisneros-Garza, LE, González-Huezo, MS, Moctezuma-Velázquez, C., de Guevara-Cetina, LL, Vilatobá, M., García-Juárez, I., ... & Torrecillas-Torres, L. (2022). The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis. Revista de Gastroenterología de México (English Edition), 87(2), 216-234. https://doi.org/10.1016/j.rgmxen.2021.10.009
De Lope, C. R., Reig, M., Matilla, A., Ferrer, M. T., Dueñas, E., Mínguez, B., ... & Liver Cancer Study Group. (2017). Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008–2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers. Medicina Clínica (English Edition), 149(2), 61-71. https://doi.org/10.1016/j.medcli.2016.12.048
El-Serag, H. B. (2011). Hepatocellular carcinoma. The New England Journal of Medicine, 365, 1118-1127. https://doi.org/10.1056/NEJMra1001683
El-Serag, H. B., & Mason, A. C. (1999). Rising incidence of hepatocellular carcinoma in the United States. New England Journal of Medicine, 340(10), 745-750. https://doi.org/10.1056/NEJM199903113401001
El–Serag, H. B., & Rudolph, K. L. (2007). Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology, 132(7), 2557-2576. https://doi.org/10.1053/j.gastro.2007.04.061
European Association for the Study of the Liver. (2012). EASL–EORTC clinical practice guidelines: Management of hepatocellular carcinoma. Journal of Hepatology, 56(4), 908-943. https://doi.org/10.1016/j.jhep.2011.12.001
Farah, M., Anugwom, C., Ferrer, J. D., Baca, E. L., Mattos, A. Z., Possebon, J. P. P., ... & Debes, J. D. (2023). Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network. Annals of Hepatology, 28(2), e100876. https://doi.org/10.1016/j.aohep.2022.100876
Fassio, E., Díaz, S., Santa, C., Reig, M. E., Artola, Y. M., de Mattos, A. A., ... & Pinchuk, L. (2010). Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study. Annals of hepatology, 9(1), 63-69.
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology, 127(5), S35-S50. https://doi.org/10.1053/j.gastro.2004.09.014
Fitzmaurice, C., Akinyemiju, T., Abera, S., et al. (2017). The burden of primary liver cancer and underlying etiologies from 1990 to 2015: Global Burden of Disease Study 2015. JAMA Oncology, 3(12), 1683-1691. https://doi.org/10.1001/jamaoncol.2017.3055
Forner, A., Ayuso, C., Real, M. I., Sastre, J., Robles, R., Sangro, B., ... & Bruix, J. (2009). Diagnóstico y tratamiento del carcinoma hepatocelular. Medicina Clínica (Barcelona), 132(7), 272-287. https://doi.org/10.1016/j.medcli.2008.11.024
Gomes, M. A., Priolli, D. G., Tralhão, J. G., & Botelho, M. F. (2013). Carcinoma hepatocelular: Epidemiologia, biologia, diagnóstico e terapias. Revista da Associação Médica Brasileira, 59(5), 514-524. https://doi.org/10.1016/j.ramb.2013.03.005
Goncalves, C. S., Pereira, F. E., & Gayotto, L. C. (1997). Hepatocellular carcinoma in Brazil: report of a national survey (Florianópolis, SC, 1995). Revista do Instituto de Medicina Tropical de São Paulo, 39, 165-170. https://doi.org/10.1590/S0036-46651997000300008
Lin, L., Yan, L., Liu, Y., Qu, C., Ni, J., & Li, H. (2020). The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017: Global Burden of Disease Study 2017. Liver Cancer, 9(5), 563-582. https://doi.org/10.1159/000508568
Marcelo, P., Hoff, G., Katz, A., Novis, Y. S., & Oliveira Filho, V. (2013). Tratado de oncologia. Atheneu.
Ministério da Saúde, Biblioteca Virtual em Saúde. (2022). Hepatites virais: Boletim epidemiológico 2022. Secretaria de Vigilância em Saúde, Ministério da Saúde.
Ministério da Saúde, Instituto Nacional de Câncer José Alencar Gomes da Silva. (2023). Estimativa 2023: Incidência de câncer no Brasil. Ministério da Saúde.
Park, J. W., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P. J., ... & Sherman, M. (2015). Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study. Liver International, 35(9), 2155-2166. https://doi.org/10.1111/liv.12818
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.
Petrick, J. L., & McGlynn, K. A. (2019). The changing epidemiology of primary liver cancer. Current Epidemiology Reports, 6(2), 104-111. https://doi.org/10.1007/s40471-019-00188-3
Petrick, J. L., Florio, A. A., Znaor, A., D., Laversanne, M., Alvarez, C. S., ... & McGlynn, K. A. (2020). International trends in hepatocellular carcinoma incidence, 1978–2012. International Journal of Cancer, 147(2), 317-330. https://doi.org/10.1002/ijc.32723
Shitsuka, R. et al. (2014). Matemática fundamental para tecnologia. (2ed.). Editora Erica.
Singal, AG., Lampertico, P., & Nahon, P. (2020). Epidemiology and surveillance for hepatocellular carcinoma: New trends. Journal of Hepatology, 72(2), 250-261. https://doi.org/10.1016/j.jhep.2019.08.025
Toassi, R. F. C. & Petry, P. C. (2021). Metodologia científica aplicada à área da Saúde. (2. ed.). Editora da UFRGS.
Varela, M., Reig, M., de la Mata, M., Matilla, A., Bustamante, J., Pascual, S., ... & Bruix, J. (2010). Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros. Medicina clínica, 134(13), 569-576. https://doi.org/10.1016/j.medcli.2009.10.042
World Health Organization. (2020). World cancer report: Cancer research for cancer development. International Agency for Research on Cancer.
Yagüe, T. M. (2004). Tumores hepáticos. Medicine: Programa de Formación Médica Continuada Acreditado, 9(10), 595-605.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Viviane Mendonça; Renata dos Santos Rabello; Fernando Fornari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
